MétaCan
Menu
Back to cohort

Small bowel adenocarcinoma and associated malignancies

2005· article· en· W2248255966 on OpenAlexaboutno aff
Shaheen Ahmed, Ruqaiya Shahid, Adnan Sami, Imad Ahmad, Subhash Yadav, D. Mirchandani, David R. Popkin, Kamal Haider

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicGastrointestinal Tumor Research and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineAdenocarcinomaMalignancyDuodenal cancerCancerInternal medicineColorectal cancerGastroenterologyFamily historyOncology

Abstract

fetched live from OpenAlex

4088 Background: Small bowel (SB) tumors are uncommon and comprise only 1–5% of gastrointestinal cancers. In the Western countries, adenocarcinoma is the most common SB tumor and represents about 28–47% of all malignant SB tumors. Limited data is available about second malignancies in SB adenocarcinoma. Our experience of second malignancies in patients with SB adenocarcinoma in a Canadian province is presented here. Methods: Patients with SB adenocarcinoma and a second malignancy diagnosed since 1958 were identified by using Saskatchewan Cancer Registry. Patients with colo-rectal cancer with extension to the SB or with metastatic adenocarcinoma to SB were excluded. Results: Twenty-two patients with SB cancer and a second cancer were identified. The median age was 73 yrs (17–81) and M: F was 1:1. 7/17 (41%) patients had smoking history and 11/14 (79%) patients had history of alcohol intake. Family history was available in 16 patients and 8/16 (50%) patients had at least 1 (1–3) first degree relative with cancer. Seventy-seven percent patients had localized disease at the time of diagnosis. Sites of involvement were as follows: Duodenum 36%, Ileum 36%, and Jejunum 27%. All except 1 patient underwent curative or palliative resection of the tumor. None had received adjuvant therapy. The median time from the diagnosis of SB adenocarcinoma to a second malignancy was 8. 5 years (0–30). Six patients had ≥1 second cancer. In 32% patients, SB adenocarcinoma was the first cancer diagnosed. Median number of second cancers was 1 (1–4) and a total of 31 second cancers were diagnosed. The frequency of second cancers were as follows: Colon cancer 45%, breast cancer 23%, prostate cancer 13%, lung cancer 6%, rectal cancer 3%, thyroid cancer 3%, cervical cancer 3%, and ovarian cancer 3%. Median follow up period was 12.5 yrs (1–36). 24% with localized SB cancer had recurrence of the disease after curative resection. Median survival from the time of diagnosis of SB adneocarcinoma was 4 yrs (0.1–29).15 patients died during follow up period. 60% patients died of small bowel cancer and 27% died of second cancer. Conclusions: An association was noted between SB adenocarcinoma and colo-rectal cancer. Moreover, a long latency period was found between SB adenocarcinoma and a second cancer. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.032

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0090.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.199
GPT teacher head0.455
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicGastrointestinal Tumor Research and TreatmentFrench-language works237,207